Rehovot, Israel

Nir Skalka

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Aummune Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nir Skalka: Innovator in Functional Aptamers

Introduction

Nir Skalka is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of functional aptamers. His innovative work has led to the filing of a patent that showcases his expertise and creativity.

Latest Patents

Nir Skalka holds a patent titled "Methods and Compositions for Selection of Functional Aptamers." This patent highlights his research and advancements in the selection process of aptamers, which are crucial for various applications in diagnostics and therapeutics. He has 1 patent to his name, reflecting his commitment to innovation in this specialized area.

Career Highlights

Nir Skalka is currently associated with Aummune Ltd., a company focused on developing novel therapeutic solutions. His role at Aummune Ltd. allows him to apply his knowledge and skills in a practical setting, contributing to the advancement of medical technologies. His work is characterized by a dedication to improving health outcomes through innovative research.

Collaborations

Nir has collaborated with notable colleagues, including Yaniv Amir and Ido Bachelet. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the field of biotechnology.

Conclusion

Nir Skalka is a dedicated inventor whose work in functional aptamers has the potential to impact the biotechnology industry significantly. His contributions through patents and collaborations demonstrate his commitment to innovation and excellence in research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…